RxDoctor Payments Data

Michelle Viveiros

Gerontology · North Kingstown, RINPI 1720448533

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $582 and has fallen 67.6% since, to $188 in 2025.

$1,453in general payments, 2019–2025

Across 68 payments — averaging $21.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$330
  • AbbVie$242
  • Amgen$94
  • Foundation Medicine, Inc.$93
  • Novartis$89
  • Incyte Corporation$66
  • plus $539 from 20 others

What the payments were for

  • Food & beverage$1,453100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,453 in reported general payments places this provider in the 75th percentile of 39 gerontology providers in Rhode Island.

See all gerontology providers in Rhode Island

Medicare billing

Part B allowed, 2024
$5,876
Medicare patients
48
Services billed
78

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban44$15,471
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate20$5,424
Morphine Sulfate ErMorphine Sulfate17$1,765
Lorazepam74$1,155
Mirtazapine36$1,119
Trazodone Hcl69$1,018
Duloxetine Hcl18$1,013
Sertraline Hcl73$883
Phenobarbital24$745
Ramelteon12$714
Lisinopril31$551
Atorvastatin Calcium28$505
Amlodipine Besylate34$505
Quetiapine Fumarate28$460
Levothyroxine Sodium39$459

Paid to pharmacies, not to this prescriber.

Other gerontology in North Kingstown

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →